CYP51A1 and colorectal carcinoma: 5-FU amplified the variation seen in CRC (for CHECK2 in HT-29, for NOS3 in HT-29 and HT-116), but opposed it (CHECK2 and CYP51A1 in HCT-116, VEGFA in HT-29, HMGCS1 in both cell lines).